FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer—A Multicenter Prospective Study Reports of MMS for early vulvar SCC are limited, but cases of successful ... ascopubs.org: Vulvar Squamous Cell Carcinoma Guidelines May Benefit From Consideration of Tissue-Sparing Techniques as Treatment Options Vulvar Squamous Cell Carcinoma Guidelines May Benefit From Consideration of Tissue-Sparing Techniques as Treatment Options Vulvar cancer is typically slow-growing and may take several years to progress without treatment. However, some types can spread more rapidly.
How fast vulvar cancer spreads depends on several factors ... In a national retrospective cohort study in England, the incidence rate of vulval squamous cell carcinoma (VSCC) remained stable from 2013 to 2022, with diagnostic delays owing to poor awareness and ... To assess efficacy and toxicity of cisplatin (C) and gemcitabine (G) with intensity-modulated radiation therapy (IMRT) in patients with locally advanced vulvar cancer not amenable to surgery. Patients ...
vulvar scc, ascopubs.org: Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279 Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279
